terbutaline has been researched along with Chronic Kidney Diseases in 1 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The purpose of this study is to determine the pharmacokinetic properties of terbutaline in patients with severe renal impairment as defined by a glomerular filtration rate (GFR) below 30 mL/min." | 2.78 | Pharmacokinetics of terbutaline in chronic kidney disease. ( Bastiansen, A; Eggert, S; Pedersen, E, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastiansen, A | 1 |
| Eggert, S | 1 |
| Pedersen, E | 1 |
1 trial available for terbutaline and Chronic Kidney Diseases
| Article | Year |
|---|---|
Pharmacokinetics of terbutaline in chronic kidney disease.
Topics: Adrenergic beta-2 Receptor Agonists; Adult; Aged; Female; Humans; Male; Middle Aged; Renal Insuffici | 2013 |